In the same way, miR-10b was described as an oncomiR in BC by targeting tumor suppressive genes (e.g., PDCD4, PTEN, TPM1), thus promoting proliferation, invasion and metastasis, and predicting the worst BC prognosis [82]. The gene discussed is TPM1; the disease is breast cancer.